Amaran Biotech, a leading Contract Development and Manufacturing Organization (CDMO) and advanced adjuvant provider, is continuing its commitment to quality excellence and operational efficiency through the implementation of a comprehensive electronic Quality Management System (eQMS), Simploud.
This strategic move is designed to ensure the highest standards of product quality and patient safety, maintain rigorous regulatory compliance and audit readiness, enhance operational efficiency, reduce costs, and improve data integrity through paperless operation.
Amaran Biotech is pleased to announce the successful rollout and go-live of the electronic Standard Operating Procedures (eSOP) module. This critical milestone signifies an important step in transitioning from paper-based quality processes to a fully digital system, ensuring streamlined documentation and enhanced control over current Good Manufacturing Practice (cGMP) activities.
Building on this success, Amaran Biotech is aggressively pursuing the next phase of its digital transformation. Within this year, the company plans to implement two other major eQMS modules: Change Control and Deviation. The integration of these electronic systems will further automate key quality processes, replacing traditional paper-based workflows. This transformation is expected to deliver significant improvements in process control, transparency, and data accuracy, reinforcing
Amaran Biotech’s position as a forward-thinking biotech dedicated to advanced quality systems and reliable service delivery.
Through the strategic adoption of Simploud’s eQMS, Amaran Biotech is solidifying its foundation for sustainable growth and demonstrating its unwavering commitment to global quality standards.